Nebenwirkungen · Pegasys
Pegasys 180 micrograms solution for injection · Abschnitt 4.8 · PDF-Seite 59–60
HOS-109892 · Präparat HOS-093265
59 Body system Very Common Uncommon Rare Very rare Frequency not common known General Pyrexia, Chest pain, disorders and rigors*, pain*, influenza like administration asthenia, illness, malaise, site conditions fatigue, lethargy, hot injection site flushes, thirst reaction*, irritability* Investigations Weight decreased Injury, poisoning Substance and procedural overdose complications *These adverse reactions were common (≥1/100 to <1/10) in CHB patients treated with Pegasys monotherapy § Class label for interferon products, see below Pulmonary arterial hypertension.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-22T12:00:00Z · SHA-256 d1a2dc533bd5ba4d4a21ad6973e4498c4ffde781c784ae67bbeeda36922e6382 · Passage 0859d77fd1f86b51841b1c7cdc4ad7552549aadaf79724d2463b89749e55e1da · Zeichen 13440–14410 im Abschnitt